Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Sales | 12,588 | 12,092 | 16,585 | 15,159 | 18,467 |
| Gross Profit | 12,588 | 12,092 | 16,585 | 15,159 | 18,467 |
| Operating Expenses | 67,199 | 60,632 | 61,804 | 60,493 | 58,479 |
| Operating Income | -54,611 | -48,540 | -45,219 | -45,334 | -40,012 |
| Other Income | 5,737 | 4,084 | 3,791 | 3,378 | 3,030 |
| Pre-tax Income | -48,874 | -44,456 | -41,428 | -41,956 | -36,982 |
| Income Tax | 82 | 90 | 90 | N/A | N/A |
| Net Income Continuous | -48,956 | -44,546 | -41,518 | -41,956 | -36,982 |
| Net Income | $-48,956 | $-44,546 | $-41,518 | $-41,956 | $-36,982 |
| EPS Basic Total Ops | -0.67 | -0.71 | -0.76 | -0.77 | -0.68 |
| EPS Basic Continuous Ops | -0.67 | -0.71 | -0.76 | -0.77 | -0.68 |
| EPS Diluted Total Ops | -0.67 | -0.71 | -0.76 | -0.77 | -0.68 |
| EPS Diluted Continuous Ops | -0.67 | -0.71 | -0.76 | -0.77 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.67 | -0.71 | -0.76 | -0.77 | N/A |
| EBITDA(a) | $-50,465 | $-44,449 | $-41,331 | $-43,545 | $-38,273 |